Dr. Sharon Rosenzweig-lipson
United States of America
Dr. Rosenzweig-Lipson has over 18 years experience developing compounds for Psychiatric and Neurologic indications in the pharmaceutical industry (American Cyanamid – American Home Products – Wyeth – Pfizer). Sharon has successfully led teams from the earliest exploratory studies through to Phase II Proof of Concept Trials. In 2011, she founded IVS Pharma Consulting LLC to bring her expertise in in screening strategies, in vivo models, translation and early clinical development strategy to the Neuroscience Scientific Community in Pharma, Biotech and Academia.